Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Published August 12, 2026 · Category: Finance

Overview

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Source

Originally published at www.marketwatch.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.